» Articles » PMID: 33522355

Long Non-coding RNA DUXAP8 Promotes the Cell Proliferation, Migration, and Invasion of Papillary Thyroid Carcinoma Via MiR-223-3p Mediated Regulation of CXCR4

Overview
Journal Bioengineered
Date 2021 Feb 1
PMID 33522355
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Papillary thyroid carcinoma (PTC) is a differentiated type of thyroid malignancy with a high incidence. Long non-coding RNA (lncRNA) DUXAP8 has been reported to participate in the proliferation, migration, and invasion of several cancer types. However, its association with PTC has not yet been reported. The current study aimed to investigate the role of DUXAP8 in PTC and revealed the underlying mechanisms. The expression of DUXAP8 was knocked down in two PTC cell lines and the effects of DUXAP8 on the PTC biological behavior were examined by cell counting kit-8 (CCK-8), wound healing, and transwell invasion assays. Luciferase reporter assay was used to detect the binding activity between miR-223-3p and DUXAP8. We found that knockdown of DUXAP8 inhibited the proliferation, migration, and invasion of PTC cells. DUXAP8 could sponge miR-223-3p through the specific binding site. CXCR4 was a target of miR-223-3p. The malignant phenotypes of the PTC cells were suppressed by the over-expression of miR-223-3p. Moreover, miR-223-3p inhibition or CXCR4 over-expression partly restored the proliferation, migration, and invasion activities of DUXAP8-downregulated PTC cells. The results evidenced that DUXAP8 acted as an oncogene in PTC, these effects seemed to partly dependent on the miR-223-3p/CXCR4 axis.

Citing Articles

Biomarkers in Thyroid Cancer: Emerging Opportunities from Non-Coding RNAs and Mitochondrial Space.

Cabane P, Correa C, Bode I, Aguilar R, Elorza A Int J Mol Sci. 2024; 25(12).

PMID: 38928426 PMC: 11204084. DOI: 10.3390/ijms25126719.


A novel prognostic N-methylguanosine-related long non-coding RNA signature in clear cell renal cell carcinoma.

Luo W, Lu J, Zheng X, Wang J, Qian S, Bai Z Sci Rep. 2023; 13(1):18454.

PMID: 37891201 PMC: 10611723. DOI: 10.1038/s41598-023-45287-w.


Clinical efficacy of gasless submental-transoral endoscopic thyroidectomy with Kirschner wire suspension for papillary thyroid carcinoma.

Chen W, Xie R, Zhang S, Zhou T, Xiong C, Huang D Am J Transl Res. 2023; 15(8):5110-5119.

PMID: 37692964 PMC: 10492077.


Unfolding of Imminent Bio-Signatures in the Prognosis of Thyroid Cancer; The Emergence of Estrogen Related Receptor Gamma (ERRγ) as a Hurricane.

Gulwani D, Upadhyay P, Goel R, Sarangthem V, Singh T Asian Pac J Cancer Prev. 2023; 24(2):375-387.

PMID: 36853284 PMC: 10162641. DOI: 10.31557/APJCP.2023.24.2.375.


Coinfection of Dermal Fibroblasts by Human Cytomegalovirus and Human Herpesvirus 6 Can Boost the Expression of Fibrosis-Associated MicroRNAs.

Soffritti I, DAccolti M, Maccari C, Bini F, Mazziga E, Arcangeletti M Microorganisms. 2023; 11(2).

PMID: 36838377 PMC: 9958881. DOI: 10.3390/microorganisms11020412.


References
1.
Xiang Z, Zhou Z, Xia G, Zhang X, Wei Z, Zhu J . A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis. Oncogene. 2017; 36(36):5122-5133. DOI: 10.1038/onc.2017.108. View

2.
Chen A, Jemal A, Ward E . Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009; 115(16):3801-7. DOI: 10.1002/cncr.24416. View

3.
Shore A, Herschkowitz J, Rosen J . Noncoding RNAs involved in mammary gland development and tumorigenesis: there's a long way to go. J Mammary Gland Biol Neoplasia. 2012; 17(1):43-58. PMC: 3637027. DOI: 10.1007/s10911-012-9247-3. View

4.
Guo Z, Yang L, Qian F, Wang Y, Yu X, Ji C . Transcription factor RUNX2 up-regulates chemokine receptor CXCR4 to promote invasive and metastatic potentials of human gastric cancer. Oncotarget. 2016; 7(15):20999-1012. PMC: 4991507. DOI: 10.18632/oncotarget.8236. View

5.
Sun M, Nie F, Zang C, Wang Y, Hou J, Wei C . The Pseudogene DUXAP8 Promotes Non-small-cell Lung Cancer Cell Proliferation and Invasion by Epigenetically Silencing EGR1 and RHOB. Mol Ther. 2017; 25(3):739-751. PMC: 5363203. DOI: 10.1016/j.ymthe.2016.12.018. View